Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Johnson and Johnson
Dow
Merck
McKinsey

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tyramine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tyramine?

Tyramine is an investigational drug.

There have been 17 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Hypercholesterolemia, Hyperlipoproteinemia Type II, and Depressive Disorder. The leading clinical trial sponsors are Regeneron Pharmaceuticals, Sanofi, and Yokohama City University.

There are two US patents protecting this investigational drug and twenty-three international patents.

Recent Clinical Trials for Tyramine
TitleSponsorPhase
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseEA Pharma Co., Ltd.Phase 2
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseYokohama City UniversityPhase 2
A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel SyndromePharmascience Inc.Phase 2

See all Tyramine clinical trials

Clinical Trial Summary for Tyramine

Top disease conditions for Tyramine
Top clinical trial sponsors for Tyramine

See all Tyramine clinical trials

US Patents for Tyramine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tyramine   Start Trial Methods for preparation of molecularly imprinted polymers for wine extraction THE TRUSTEES OF DARTMOUTH COLLEGE (Hanover, NH)   Start Trial
Tyramine   Start Trial Biocompatible tissue graft The Cleveland Clinic Foundation (Cleveland, OH)   Start Trial
Tyramine   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tyramine

Drugname Country Document Number Estimated Expiration Related US Patent
Tyramine World Intellectual Property Organization (WIPO) 2014062632 2032-10-15   Start Trial
Tyramine World Intellectual Property Organization (WIPO) 2016033337 2034-08-27   Start Trial
Tyramine World Intellectual Property Organization (WIPO) 2014052836 2032-09-27   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Mallinckrodt
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.